Verastem (VSTM) Other Gross PP&E Adjustments (2011 - 2026)
Verastem's quarterly Other Gross PP&E Adjustments came in at -$3.8 million in Q1 2026, down 163.26% year-on-year from $6.0 million in Q1 2025, and down 1219.23% quarter-over-quarter from $338000.0 in Q4 2025.
Verastem has reported Other Gross PP&E Adjustments for 16 years, with the latest figure at -$3.8 million in Q1 2026.
- For the quarter ending Q1 2026, Other Gross PP&E Adjustments fell 163.26% year-over-year to -$3.8 million; the trailing twelve-month figure through Mar 2026 stood at -$3.8 million (down 163.26% YoY), and the FY2025 full-year result was $338000.0, up 113.43% from the prior year.
- Other Gross PP&E Adjustments for Q1 2026 stood at -$3.8 million, down from $338000.0 in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was $338000.0 in Q4 2025, with the low at -$3.8 million in Q1 2026.
- Average Other Gross PP&E Adjustments over 5 years is -$1.7 million, with a median of -$1.5 million recorded in 2025.
- Year-over-year, Other Gross PP&E Adjustments plunged 318.11% in 2024 and jumped 113.43% in 2025.
- Tracing VSTM's Other Gross PP&E Adjustments over 5 years: stood at -$1.2 million in 2022, then jumped by 49.24% to -$602000.0 in 2023, then sank by 318.11% to -$2.5 million in 2024, then jumped by 113.43% to $338000.0 in 2025, then tumbled by 1219.23% to -$3.8 million in 2026.
- The last three Other Gross PP&E Adjustments figures came in at -$3.8 million (Q1 2026), $338000.0 (Q4 2025), and -$1.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Verastem | 425.60 Mn | 243.93 Mn | 15.90 Mn | -3.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.78 Mn |
| Mar 31, 2026 | -3.78 Mn |
| Dec 31, 2025 | 338,000.00 |
| Dec 31, 2025 | 338,000.00 |
| Sep 30, 2025 | -1.39 Mn |
| Sep 30, 2025 | -1.39 Mn |
| Jun 30, 2025 | -1.46 Mn |
| Jun 30, 2025 | -1.46 Mn |
| Mar 31, 2025 | -1.44 Mn |
| Mar 31, 2025 | -1.44 Mn |
| Dec 31, 2024 | -2.52 Mn |
| Dec 31, 2024 | -2.52 Mn |
| Sep 30, 2024 | -1.43 Mn |
| Sep 30, 2024 | -1.43 Mn |
| Jun 30, 2024 | -1.24 Mn |
| Jun 30, 2024 | -1.24 Mn |
| Mar 31, 2024 | -1.27 Mn |
| Mar 31, 2024 | -1.27 Mn |
| Dec 31, 2023 | -602,000.00 |
| Dec 31, 2023 | -602,000.00 |
| Sep 30, 2023 | -2.09 Mn |
| Sep 30, 2023 | -2.09 Mn |
| Jun 30, 2023 | -1.76 Mn |
| Jun 30, 2023 | -1.76 Mn |
| Mar 31, 2023 | -1.87 Mn |
| Mar 31, 2023 | -1.87 Mn |
| Dec 31, 2022 | -1.19 Mn |
| Dec 31, 2022 | -1.19 Mn |
| Sep 30, 2022 | -2.70 Mn |
| Sep 30, 2022 | -2.70 Mn |
| Jun 30, 2022 | -2.28 Mn |
| Jun 30, 2022 | -2.28 Mn |
| Mar 31, 2022 | -2.46 Mn |
| Mar 31, 2022 | -2.46 Mn |
| Dec 31, 2021 | -1.44 Mn |
| Dec 31, 2021 | -1.44 Mn |
| Sep 30, 2021 | -2.64 Mn |
| Sep 30, 2021 | -2.64 Mn |
| Jun 30, 2021 | -3.03 Mn |
| Jun 30, 2021 | -3.03 Mn |
| Mar 31, 2021 | -2.85 Mn |
| Mar 31, 2021 | -2.85 Mn |
| Dec 31, 2020 | -4.88 Mn |
| Dec 31, 2020 | -4.88 Mn |
| Sep 30, 2020 | -3.48 Mn |
| Sep 30, 2020 | -3.48 Mn |
| Jun 30, 2020 | -3.35 Mn |
| Jun 30, 2020 | -3.35 Mn |
| Mar 31, 2020 | -3.20 Mn |
| Mar 31, 2020 | -3.20 Mn |
| Dec 31, 2019 | -5.64 Mn |
| Dec 31, 2019 | -5.64 Mn |
| Sep 30, 2019 | -3.81 Mn |
| Sep 30, 2019 | -3.81 Mn |
| Jun 30, 2019 | -3.67 Mn |
| Jun 30, 2019 | -3.67 Mn |
| Mar 31, 2019 | -3.53 Mn |
| Mar 31, 2019 | -3.53 Mn |
| Dec 31, 2018 | -1.88 Mn |
| Dec 31, 2018 | -1.88 Mn |
| Sep 30, 2018 | -720,000.00 |
| Sep 30, 2018 | -720,000.00 |
| Jun 30, 2018 | -472,000.00 |
| Jun 30, 2018 | -472,000.00 |
| Mar 31, 2018 | -435,000.00 |
| Mar 31, 2018 | -435,000.00 |
| Dec 31, 2017 | 1.06 Mn |
| Dec 31, 2017 | 1.06 Mn |
| Sep 30, 2017 | -608,000.00 |
| Sep 30, 2017 | -608,000.00 |
| Jun 30, 2017 | -346,000.00 |
| Jun 30, 2017 | -346,000.00 |
| Mar 31, 2017 | -610,000.00 |
| Mar 31, 2017 | -610,000.00 |
| Dec 31, 2016 | 533,000.00 |
| Dec 31, 2016 | 533,000.00 |
| Sep 30, 2016 | -408,000.00 |
| Sep 30, 2016 | -408,000.00 |
| Jun 30, 2016 | -310,000.00 |
| Jun 30, 2016 | -310,000.00 |
| Mar 31, 2016 | -412,000.00 |
| Mar 31, 2016 | -412,000.00 |
| Dec 31, 2015 | -824,000.00 |
| Dec 31, 2015 | -824,000.00 |
| Sep 30, 2015 | -325,000.00 |
| Sep 30, 2015 | -325,000.00 |
| Jun 30, 2015 | -290,000.00 |
| Jun 30, 2015 | -290,000.00 |
| Mar 31, 2015 | -263,000.00 |
| Mar 31, 2015 | -263,000.00 |
| Dec 31, 2014 | 2.96 Mn |
| Dec 31, 2014 | 2.96 Mn |
| Sep 30, 2014 | -313,000.00 |
| Sep 30, 2014 | -313,000.00 |
| Jun 30, 2014 | -275,000.00 |
| Jun 30, 2014 | -275,000.00 |
| Mar 31, 2014 | -325,000.00 |
| Mar 31, 2014 | -325,000.00 |
| Dec 31, 2013 | 907,000.00 |
| Dec 31, 2013 | 907,000.00 |
| Sep 30, 2013 | -375,000.00 |
| Sep 30, 2013 | -375,000.00 |
| Jun 30, 2013 | -316,000.00 |
| Jun 30, 2013 | -316,000.00 |
| Mar 31, 2013 | -269,000.00 |
| Mar 31, 2013 | -269,000.00 |
| Dec 31, 2012 | 905,000.00 |
| Dec 31, 2012 | 905,000.00 |
| Sep 30, 2012 | -252,000.00 |
| Sep 30, 2012 | -252,000.00 |
| Jun 30, 2012 | -133,000.00 |
| Jun 30, 2012 | -133,000.00 |
| Dec 31, 2011 | 272,000.00 |
| Dec 31, 2011 | 272,000.00 |